Finance

Lists
Why is BHVN down ४.२९%?
Dive Deeper
BHVN:NYSE
Biohaven Ltd
US$ १०.९३
-४.२९%
(-०.४९) 1D
US$ १०.८४
-०.८२% (-०.०९०)
After hours
Closed: अक्टोबर १४, १६:००:०२ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHVN...
Open
US$ ११.३९
High
US$ ११.५०
Low
US$ १०.८२
Mkt. cap
१.६५ अरब
Avg. vol.
२७.४० लाख
Volume
१७.७८ लाख
52-wk high
US$ १८.५७
52-wk low
US$ ७.४८
EPS
-US$ ४.६४
Beta
३.१९
Shares outstanding
१५.१० करोड
No. of employees
२७४
Open
US$ ११.३९
High
US$ ११.५०
Low
US$ १०.८२
Mkt. cap
१.६५ अरब
Avg. vol.
२७.४० लाख
Volume
१७.७८ लाख
52-wk high
US$ १८.५७
52-wk low
US$ ७.४८
EPS
-US$ ४.६४
Beta
३.१९
Shares outstanding
१५.१० करोड
No. of employees
२७४
News stories
From web sources and news partners
About Biohaven Ltd
CEO-
Employees२७४
Founded२०२२
Headquartersन्यू हेवन, कनेक्टिकट, संयुक्त राज्य अमेरिका
Sector-
Websitebiohaven.com
Analyst ratings
Based on 11 analysts giving stock ratings to BHVN in the past 3 months
Buy
Buy
7
Hold
3
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for BHVN in the last 3 months.
Highest
Current US$ १०.९३
US$ ३०.०० (+१७४.४७%)
Average
US$ १९.६३ (+७९.६०%)
Lowest
US$ १०.०० (-८.५१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dina Ramadane
Bank of America Securities
Sell
Maintained
US$ ११.००
+०.६%
10/12/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
US$ २१.००
+९२.१%
10/09/2026
Samantha Semenkow
Citi
Buy
Maintained
US$ १७.००
+५५.५%
09/17/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
09/13/2026
Douglas Tsao
H.C. Wainwright
Hold
Maintained
US$ १०.००
-८.५%
09/10/2026
Christopher Raymond
Raymond James
Buy
Maintained
-
-
09/10/2026
Myles Minter
William Blair
Hold
Reiterated
-
-
09/09/2026
Leonid Timashev
RBC Capital
Hold
Downgraded
US$ १९.००
+७३.८%
09/08/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
US$ ३०.००
+१७४.५%
08/17/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
US$ १९.००
+७३.८%
08/12/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
US$ ३०.००
+१७४.५%
08/11/2026
David Hoang
Deutsche Bank
Buy
Reiterated
US$ २०.००
+८३%
06/26/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
US$ २५.००
+१२८.७%
05/28/2026
Ashwani Verma
UBS
Hold
Reiterated
US$ ११.००
+०.६%
05/28/2026
Unknown Analyst
Bernstein
Hold
Maintained
US$ ९.००
-१७.७%
05/13/2026
Last report
२०२६ अगस्ट १०
Fiscal period
Q2 2026
-US$ ०.७८ / -US$ ०.६१
-२७.६१%miss
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१४.१२ करोड
८.४९ करोड
१०.३८ करोड
१०.०८ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.८२ करोड
२.०८ करोड
२.६६ करोड
२.४१ करोड
Operating expense
१६.९४ करोड
१०.५७ करोड
१३.०४ करोड
१२.४९ करोड
Total operating expenses
१६.९४ करोड
१०.५७ करोड
१३.०४ करोड
१२.४९ करोड
Operating income
-१६.९४ करोड
-१०.५७ करोड
-१३.०४ करोड
-१२.४९ करोड
Other non operating income
-७२.५० लाख
-५२.८६ लाख
-३०.८२ लाख
-१.४७ करोड
EBT including unusual items
-१७.३२ करोड
-१४.५२ करोड
-१३.०३ करोड
-१३.६९ करोड
EBT excluding unusual items
-१७.६६ करोड
-११.१० करोड
-१३.३५ करोड
-१३.९६ करोड
Income tax expense
२.२१ लाख
३.५१ लाख
२.७२ लाख
३.९१ लाख
Effective tax rate
-०.१३%
-०.२४%
-०.२१%
-०.२९%
Other operating expenses
-
-
-
-
Net income
-१७.३४ करोड
-१४.५६ करोड
-१३.०५ करोड
-१३.७३ करोड
Net profit margin
-
-
-
-
Earnings per share
-१.४७
-०.९०
-०.६९
-०.७८
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-१६.६३ करोड
-१०.३२ करोड
-१२.८१ करोड
-१२.२६ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू